Nizatidine
- Generic Name
- Nizatidine
- Brand Names
- Axid
- Drug Type
- Small Molecule
- Chemical Formula
- C12H21N5O2S2
- CAS Number
- 76963-41-2
- Unique Ingredient Identifier
- P41PML4GHR
Overview
A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.
Background
A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.
Indication
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
Associated Conditions
- Duodenal Ulcer
- Esophagitis
- Gastric Ulcer
- Gastro-esophageal Reflux Disease (GERD)
- Helicobacter Pylori Infection
- Peptic Ulcer Disease
- Stress Ulcers
Clinical Trials
FDA Approved Products
Nizatidine
Manufacturer:nizatidine
Route:ORAL
Strength:150 mg in 1 1
Approved: 2010/01/14
NDC:16590-741
Nizatidine
Manufacturer:Dr Reddy's Laboratories Limited
Route:ORAL
Strength:300 mg in 1 1
Approved: 2018/12/06
NDC:55111-311
Nizatidine
Manufacturer:Dr Reddy's Laboratories Limited
Route:ORAL
Strength:150 mg in 1 1
Approved: 2018/12/06
NDC:55111-310
Nizatidine
Manufacturer:Carilion Materials Management
Route:ORAL
Strength:150 mg in 1 1
Approved: 2016/10/13
NDC:68151-0017
Nizatidine
Manufacturer:NuCare Pharmaceuticals,Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2021/02/19
NDC:68071-5043
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath